Intelligent Medicine Acquisition Corp. Warrant
IQMDW
IQMDW was delisted on the 26th of April, 2023.
40 hedge funds and large institutions have $3.62M invested in Intelligent Medicine Acquisition Corp. Warrant in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
600% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 4
150% more funds holding
Funds holding: 16 → 40 (+24)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
12% less capital invested
Capital invested by funds: $4.11M → $3.62M (-$490K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$182K |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$128K |
| 3 |
LA
Linden Advisors
New York
|
+$100K |
| 4 |
SC
Sculptor Capital
New York
|
+$91.1K |
| 5 |
SCM
Saba Capital Management
New York
|
+$78.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$138K |
| 2 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$73K |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$59K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$18.2K |
| 5 |
CS
Clear Street
New York
|
-$3K |
IQMDW Hedge Fund Activity: Q1 2022 in Review
40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Warrant (IQMDW) for Q1 2022, worth a combined $3.62M — down 12% from $4.11M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new IQMDW positions and 4 closed out — a net gain of 24 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was MMCAP International, opening a new position worth an estimated $182K. The largest seller was Beryl Capital Management, exiting entirely with an estimated $138K sold.
- 40 institutional investors held Intelligent Medicine Acquisition Corp. Warrant (IQMDW) as of Q1 2022, up from 16 in Q4 2021.
- Funds reported $3.62M of Intelligent Medicine Acquisition Corp. Warrant stock for Q1 2022, down 12% quarter-over-quarter.
- 28 funds opened new Intelligent Medicine Acquisition Corp. Warrant positions in Q1 2022 and 4 closed out, a net change of +24 holders.
- The largest Intelligent Medicine Acquisition Corp. Warrant buyer in Q1 2022 was MMCAP International, an estimated $182K added.
- The largest Intelligent Medicine Acquisition Corp. Warrant seller in Q1 2022 was Beryl Capital Management, an estimated $138K sold.
Based on aggregated 13F filings for Q1 2022.